Kynam Capital Management, LP Wave Life Sciences Ltd. Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Kynam Capital Management, LP holds 3,975,521 shares of WVE stock, worth $55 Million. This represents 1.54% of its overall portfolio holdings.
Number of Shares
3,975,521
Previous 3,932,082
1.1%
Holding current value
$55 Million
Previous $24.3 Million
18.23%
% of portfolio
1.54%
Previous 2.55%
Shares
9 transactions
Others Institutions Holding WVE
# of Institutions
147Shares Held
94MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$252 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$106 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$93.2 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$85.3 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$74.1 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.2B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...